Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03428958
Title A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
Recruitment Completed
Gender
Phase Phase I
Variant Requirements No
Sponsors NuCana plc
Indications
Therapies
Age Groups:
Covered Countries USA | GBR | FRA

Facility Status City State Zip Country Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
Seattle Cancer Center Seattle Washington 98109-1023 United States Details
Compass Oncology Vancouver Washington 98684 United States Details
Hopital Franco-Britannique Levallois-Perret 92300 France Details
The Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
University College London Hospitals NHS Foundation Trust London W1T 7HA United Kingdom Details
University of Oxford Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field